Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Michael S. Lee, Baek Yeol Ryoo, Chih Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P. Hack, Jessica Spahn, Bo Liu, Heba Abdullah, Yulei Wang, Aiwu Ruth He, Kyung Hun Lee, Y. J. Bang, J. Bendell, Y. Chao, J. S. Chen, H. C. Chung, S. L. Davis, A. DevE. Gane, B. George, A. R. He, H. Hochster, C. H. Hsu, M. Ikeda, J. Lee, M. Lee, A. Mahipal, G. Manji, M. Morimoto, K. Numata, M. Pishvaian, S. Qin, D. Ryan, B. Y. Ryoo, N. Sasahira, S. Stein, J. Strickler, N. Tebbutt

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study'. Together they form a unique fingerprint.

Medicine & Life Sciences